AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak
AstraZeneca will push through with its other Phase 3 studies for volrustomig, including in cervical cancer and mesothelioma.
AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak Read More »
